Those devices were an Apple Watch Series 10, a Fitbit Charge 6, a Garmin Forerunner 265S, an Oura Ring 4, and a Whoop 4.0.

The device has evolved from one aimed at just functional MR to a broader HF therapy. EMPOWER will provide more insights.

The revolutionary BiVACOR heart device was moved to Phase 2 of FDA trials after success in five human patients.

Smartwatches have grown from obscure gadgets and fashion accessories to comprehensive health and fitness trackers in just a few short years. As of early 2024, the market has devices with a wide range ...